One perk of this ingredient is that it is very stable, resistant to oxidation, and unlikely to go rancid
Used in apoptosis pathway studies, p53-FOXO4 interaction research, and senescent cell clearance investigations
[PMID: 19258736] PubMed record related to this compound for laboratory literature review
Outcome signal Cellular support Evidence cue Longevity research Decision rhythm Start / Compare / Explore Best-fit signals Choose Epithalon (Epitalon) when these match your goal Frequently researched together Build a peptide stack before checkout Selected stack $1208 Save $149 with stack pricing Save $134 more with subscribe-and-save 3 products 3-month plan ships quarterly 10% stack discount 10% subscribe discount Plan length Pay every 3 months Ships every 3 months Decision timeline What to expect as you compare Epithalon (Epitalon) Timelines vary by goal, dose, baseline health, and consistency
The medication should be kept out of sight and reach of children
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know On April 15, 2026, the FDA announced a significant regulatory update: injectable GHK-Cu (copper tripeptide-1) will be removed from the Category 2 bulk substances list by July 2026